Showing 11,021 - 11,040 results of 11,110 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((teer decrease) OR (nn decrease)) ))', query time: 0.75s Refine Results
  1. 11021

    Table3_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  2. 11022

    Image2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  3. 11023

    Table4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  4. 11024

    Image4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  5. 11025

    Table2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  6. 11026

    Image3_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tif by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  7. 11027

    Table2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  8. 11028

    Image1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  9. 11029

    Image4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  10. 11030

    Image1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  11. 11031

    Table4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…We evaluated the PASI score of mice on day 7 and found that SHI and DMA also alleviated psoriatic lesions (MD = -3.36, 95% CI [-4.67, -2.05], p < 0.00001, I<sup>2</sup> = 94%). Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  12. 11032

    Trends of HIV/AIDS in Ethiopia (1990-2021). by Tegene Atamenta Kitaw (17930374)

    Published 2025
    “…There was a significant decline in the age-standardized HIV incidence rate, from 175.4 per 100,000 in 1990 to 22.4 per 100,000 in 2021, with an average annual percentage change (AAPC) of -6.64% (p <  0.001). …”
  13. 11033
  14. 11034

    Table 1_Correlation of serum irisin levels with diabetic nephropathy: an exhaustive systematic appraisal and meta-analytical investigation.xls by Yuan Deng (177795)

    Published 2025
    “…Specifically, irisin levels were significantly reduced in patients with microalbuminuria (MD = 30.84, 95% CI: 7.81 to 53.87, I² = 96%) and macroalbuminuria (MD = 30.84, 95% CI: 7.81 to 53.87, I² = 98%) compared to those with normoalbuminuria. Furthermore, a direct comparison between microalbuminuria and macroalbuminuria also revealed significantly lower irisin levels in the latter group (MD = 12.53, 95% CI: 3.46 to 21.59, I² = 89%). …”
  15. 11035

    Table_2_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  16. 11036

    Image_3_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  17. 11037

    Image_4_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  18. 11038

    Image_7_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  19. 11039

    Table_3_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  20. 11040

    Image_1_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.jpeg by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”